BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Debt Ratio (2023 - 2026)

BioAge Labs' (BIOA) quarterly Debt Ratio came in at 0.0 in Q1 2026, down 85.8% year-over-year from 0.02 in Q1 2025, and down 67.54% quarter-over-quarter from 0.01 in Q4 2025.

Analysis

BioAge Labs (BIOA) Debt Ratio (2023 - 2026) Analysis & Trends

BioAge Labs has disclosed Debt Ratio across 4 years of filings, most recently posting 0.0 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 85.8% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 85.8% YoY), while the FY2025 annual figure was 0.01, down 62.16% from the prior year.
  • Debt Ratio came in at 0.0 for Q1 2026 at BioAge Labs, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.55 in Q4 2023 to a low of 0.0 in Q1 2026.
  • Average Debt Ratio over 4 years is 0.08, with a median of 0.02 recorded in 2025.
  • Year-over-year, Debt Ratio sank 95.67% in 2024 and plunged 54.1% in 2025.
  • Over 4 years, Debt Ratio stood at 0.55 in 2023, then slumped by 95.67% to 0.02 in 2024, then slumped by 62.16% to 0.01 in 2025, then plunged by 67.54% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 0.66
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 0.05
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 0.05
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 0.25
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 BioAge Labs 409.83 Mn 409.83 Mn -14.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.03
Dec 31, 2023 0.55